Cipla to build plant in South Africa | Chemical & Engineering News
Volume 94 Issue 29 | p. 15 | Concentrates
Issue Date: July 18, 2016

Cipla to build plant in South Africa

Department: Business
Keywords: biosimilars, investment, Africa, drug access, cancer

The Indian generic drugs company Cipla will spend about $20 million to build a biosimilars plant in Durban, South Africa. Scheduled to come on-line in 2018, the plant, which will mostly produce cancer drugs, will employ about 300 people. Cipla says it hopes that its investment will help make biologic drugs affordable for 20% of the country’s patients, up from just 2% currently.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment